Warning issued for J&J; drug
- Share via
From Times Wire Reports
Johnson & Johnson and the Food and Drug Administration warned of reported liver damage and death in patients taking the company’s HIV drug Prezista, according to a letter released Wednesday.
The letter, which J&J; sent to doctors this month, cited cases of drug-induced hepatitis, liver injury and death, though the problems have not been linked directly to Prezista, a protease inhibitor given in combination with Abbott Laboratories’ ritonavir. A J&J; unit said it would put a new warning on the label.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
